APA (7th ed.) Citation

Nikolaos Giannelos, Cheryl Ng, & Desmond Curran. (2023). Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Nikolaos Giannelos, Cheryl Ng, and Desmond Curran. Cost-effectiveness of the Recombinant Zoster Vaccine (RZV) Against Herpes Zoster: An Updated Critical Review. Taylor & Francis Group, 2023.

MLA (9th ed.) Citation

Nikolaos Giannelos, et al. Cost-effectiveness of the Recombinant Zoster Vaccine (RZV) Against Herpes Zoster: An Updated Critical Review. Taylor & Francis Group, 2023.